In 2023, sales of antiinfective medicines in Italy were valued at approximately 4.35 billion US dollars PPP. Forecasted sales indicate a steady growth from 2024 to 2028, with annual increases ranging from 2.91% to 2.74%. The compound annual growth rate (CAGR) over the five-year period is expected to be around 2.78%, suggesting a consistent upward trend.

Future trends to monitor include:

Advancements in pharmaceutical technologies and innovation in antiinfective therapies.
Changes in regulatory policies affecting drug pricing and reimbursement.
Impact of global health challenges and antibiotic resistance on sales dynamics.